DICER1 and glioblastoma: Clinical studies have reported that lower Dicer expression was significantly correlated with poor prognosis in multiple cancers, such as ovarian cancer [13], glioblastoma [9], renal cell cancer [39], liver cancer [40], and lung cancer [41].